Orthopaedics

Conrozier T, Jerosch J, Beks P, Kemper F, Euller-Ziegler L, Bailleul F, Chevalier X. 2008. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study. Arch Ortho and Trauma Surg 1-7 [26 Mar 2009 E-Pub ahead of print].

Levine DW, Mondano L, Halpin M. 2008. FDA regulatory pathways for knee cartilage repair products. Sports Med Arthrosc 16(4):202-7.

Sun L, Vukicevic S, Baliram R, Yang G, Sendak R, McPherson J, Zhu L-L, Iqbal J, Latif R, Natrajan A, Arabi A, Yamoah K, Moonga BS, Gabet Y, Davies TF, Bab I, Abe E, Sampath K, Zaidi M. 2008. Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proc. of the Natl. Acad. of Sci. of the U.S.A. 105 (11):4289-94.

Bellamy N, Bell MJ, Pericak D, Goldsmith CH, Torrance GW, Raynauld JP, Walker V, Tugwell P, Polisson R. 2007. BLISS index for analyzing knee osteoarthritis trials data. J Clin Epidemiol 60:124-132.

Dimicco MA, Kisiday JD, Gong H, Grodzinsky AJ. 2007. Structure of pericellular matrix around agarose-embedded chondrocytes. Osteoarthritis Cartilage 15:1207-1216.

Hayes AJ, Hall A, Brown L, Tubo R, Caterson B. 2007. Macromolecular organization and in vitro growth characteristics of scaffold-free neocartilage grafts. J Histochem Cytochem.

Miceli C. 2007. Products: US approval for new labelling for knee treatment. Biomed Materials 3-4.

Rapko S, Baron U, Hoffmüller U, Model F, Wolfe L, Olek S. 2007. DNA methylation analysis as novel tool for quality control in regenerative medicine. Tissue Eng.

Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S. 2007. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. J Bone Miner Res 22:849-859.

Sendak RA, Sampath TK, McPherson JM. 2007. Newly reported roles of thyroid-stimulating hormone and follicle-stimulating hormone in bone remodelling. Int Orthop.

Bellamy N, Bell MJ, Goldsmith CH, Pericak D, Walker V, Raynauld JP, Torrance GW, Tugwell P, Polisson R. 2005. Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis. Ann Rheum Dis 64:881-885.

Bellamy N, Bell MJ, Goldsmith CH, Pericak D, Walker V, Raynauld JP, Torrance GW, Tugwell P, Polisson R. 2005. The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI. Osteoarthritis Cartilage 13:104-110.

Burns JW, Kraines JL, Magilavy DB, Murray CW, Richards SM. 2005. Response to: Identification of an immunogenic candidate for the elicitation of severe acute inflammatory reactions (SAIRs) to hylan G-F 20. Osteoarthritis Cartilage.

Kemper F, Gebhardt U, Meng T, Murray, C. 2005. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin 21(8):1261-1269.

Kielpinski G, Prinzi S, Duguid J, du Moulin G. 2005. Roadmap to approval: Use of an automated sterility test method as a lot release test for Carticel, autologous cultured chondrocytes. Cytother 7:531-541

Raynauld JP, Goldsmith CH, Bellamy N, Torrance GW, Polisson R, Belovich D, Pericak D, Tugwell P. 2005. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis Cartilage 13:111-119.

Schreiber RE, Blease K, Ambrosio A, Amburn E, Sosnowski B, Sampath TK. 2005. Bone induction by AdBMP-2/collagen implants. J Bone Joint Surg Am 87:1059-1068.

Bellamy N, Bell M, Goldsmith C, Pericak D, Walker V, Raynauld JP, Torrance G, Tugwell P, Polisson R. 2004. Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis. Ann Rheum Dis.

Magilavy DB, McPherson JM, Polisson R. 2004. Pseudoseptic reactions to Hylan viscosupplementation: diagnosis and treatment. Clin Orthop Relat Res:349-350; author reply 350-341.

Brown L, Gleneck K, DeBenedetto P, Sampath TK. 2003. Generation of an implantable cartilaginous graft using mesenchymal stem cells derived from human bone marrow. Tissue Engineering 9:826.

Furst DE, Weisman M, Paulus HE, Bulpitt K, Weinblatt M, Polisson R, Zaug M, Kneer J, Van der Auwera P, Stevens RM. 2003. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis. J Rheumatol 30:2123-2126.

Magilavy D, Polisson R, Parenti D. 2003. Re: Karlsson et al. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford) 42:1262; author reply 1262-1263.

Magilavy D, Polisson R, Murray C. 2003. Acute local reaction to intra-articular Hylan G-F 20 (Synvisc): part I. J Bone Joint Surg Am 85-A:1618-1619; author reply 1619-1620.

Sumner DR, Turner TM, Cohen M, Losavio P, Urban RM, Nichols EH, McPherson JM. 2003. Aging does not lessen the effectiveness of TGFbeta2-enhanced bone regeneration. J Bone Miner Res 18:730-736.

Gerstenfeld LC, Cruceta J, Shea CM, Sampath K, Barnes GL, Einhorn TA. 2002. Chondrocytes provide morphogenic signals that selectively induce osteogenic differentiation of mesenchymal stem cells. J Bone Miner Res 17:221-230.